A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
Clinical trial NCT02727660 · COMPLETED
Trial details
- NCT number
- NCT02727660
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-29
- Primary completion
- 2018-04-04
- Enrollment
- 1876
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.